Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Harrison C. Brown
244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Related publications
AAV-mediated Gene Transfer for Hemophilia
Genetics in Medicine
Medicine
Genetics
Postpartum Acquired Hemophilia Factor VIII �nhibitors and Response to Therapy
Turkish Journal of Haematology
Hematology
Immune Tolerance Induced by Platelet-Targeted Factor VIII Gene Therapy in Hemophilia a Mice Is CD4 T Cell-Mediated
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Lentivirus-Mediated Platelet Gene Therapy of Murine Hemophilia a With Pre-Existing Anti-Factor VIII Immunity
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Creating a DDAVP Releasable Pool of Factor VIII: Its Impact on the Gene Therapy of Hemophilia a † 786
Pediatric Research
Child Health
Pediatrics
Perinatology
Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice
Journal of Pharmaceutical Sciences
Pharmaceutical Science
HLA-DRB1–factor VIII Binding Is a Risk Factor for Inhibitor Development in Nonsevere Hemophilia: A Case-Control Study
Blood advances
Hematology